Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Passive Transdermal Drug Delivery market report explains the definition, types, applications, major countries, and major players of the Passive Transdermal Drug Delivery market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Novartis AG
Mylan NV
Noven Pharmaceuticals Inc
Johnson & Johnson (Janssen Pharmaceuticals Inc)
Transdermal Corp
Corium International Inc
Actavis Inc
GlaxoSmithKline plc
Bayer AG
Echo Therapeutics Inc
3M
Boehringer Ingelheim GmbH
By Type:
Microfluidics
Smart Pill Technology (SPT)
By End-User:
Clinic
Hospital
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Passive Transdermal Drug Delivery Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Passive Transdermal Drug Delivery Outlook to 2028- Original Forecasts
-
2.2 Passive Transdermal Drug Delivery Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Passive Transdermal Drug Delivery Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Passive Transdermal Drug Delivery Market- Recent Developments
-
6.1 Passive Transdermal Drug Delivery Market News and Developments
-
6.2 Passive Transdermal Drug Delivery Market Deals Landscape
7 Passive Transdermal Drug Delivery Raw Materials and Cost Structure Analysis
-
7.1 Passive Transdermal Drug Delivery Key Raw Materials
-
7.2 Passive Transdermal Drug Delivery Price Trend of Key Raw Materials
-
7.3 Passive Transdermal Drug Delivery Key Suppliers of Raw Materials
-
7.4 Passive Transdermal Drug Delivery Market Concentration Rate of Raw Materials
-
7.5 Passive Transdermal Drug Delivery Cost Structure Analysis
-
7.5.1 Passive Transdermal Drug Delivery Raw Materials Analysis
-
7.5.2 Passive Transdermal Drug Delivery Labor Cost Analysis
-
7.5.3 Passive Transdermal Drug Delivery Manufacturing Expenses Analysis
8 Global Passive Transdermal Drug Delivery Import and Export Analysis (Top 10 Countries)
-
8.1 Global Passive Transdermal Drug Delivery Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Passive Transdermal Drug Delivery Export by Region (Top 10 Countries) (2017-2028)
9 Global Passive Transdermal Drug Delivery Market Outlook by Types and Applications to 2022
-
9.1 Global Passive Transdermal Drug Delivery Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Microfluidics Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Smart Pill Technology (SPT) Consumption and Growth Rate (2017-2022)
-
9.2 Global Passive Transdermal Drug Delivery Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Passive Transdermal Drug Delivery Market Analysis and Outlook till 2022
-
10.1 Global Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.2.2 Canada Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.2.3 Mexico Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.3.2 UK Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.3.3 Spain Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.3.4 Belgium Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.3.5 France Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.3.6 Italy Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.3.7 Denmark Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.3.8 Finland Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.3.9 Norway Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.3.10 Sweden Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.3.11 Poland Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.3.12 Russia Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.3.13 Turkey Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.4.2 Japan Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.4.3 India Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.4.4 South Korea Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.4.5 Pakistan Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.4.6 Bangladesh Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.4.7 Indonesia Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.4.8 Thailand Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.4.9 Singapore Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.4.10 Malaysia Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.4.11 Philippines Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.4.12 Vietnam Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.5.2 Colombia Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.5.3 Chile Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.5.4 Argentina Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.5.5 Venezuela Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.5.6 Peru Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.5.7 Puerto Rico Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.5.8 Ecuador Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.6.2 Kuwait Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.6.3 Oman Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.6.4 Qatar Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.6.5 Saudi Arabia Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.6.6 United Arab Emirates Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.7.2 South Africa Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.7.3 Egypt Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.7.4 Algeria Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Passive Transdermal Drug Delivery Consumption (2017-2022)
-
10.8.2 New Zealand Passive Transdermal Drug Delivery Consumption (2017-2022)
11 Global Passive Transdermal Drug Delivery Competitive Analysis
-
11.1 Novartis AG
-
11.1.1 Novartis AG Company Details
-
11.1.2 Novartis AG Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Novartis AG Passive Transdermal Drug Delivery Main Business and Markets Served
-
11.1.4 Novartis AG Passive Transdermal Drug Delivery Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Mylan NV
-
11.2.1 Mylan NV Company Details
-
11.2.2 Mylan NV Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Mylan NV Passive Transdermal Drug Delivery Main Business and Markets Served
-
11.2.4 Mylan NV Passive Transdermal Drug Delivery Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Noven Pharmaceuticals Inc
-
11.3.1 Noven Pharmaceuticals Inc Company Details
-
11.3.2 Noven Pharmaceuticals Inc Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Noven Pharmaceuticals Inc Passive Transdermal Drug Delivery Main Business and Markets Served
-
11.3.4 Noven Pharmaceuticals Inc Passive Transdermal Drug Delivery Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Johnson & Johnson (Janssen Pharmaceuticals Inc)
-
11.4.1 Johnson & Johnson (Janssen Pharmaceuticals Inc) Company Details
-
11.4.2 Johnson & Johnson (Janssen Pharmaceuticals Inc) Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Johnson & Johnson (Janssen Pharmaceuticals Inc) Passive Transdermal Drug Delivery Main Business and Markets Served
-
11.4.4 Johnson & Johnson (Janssen Pharmaceuticals Inc) Passive Transdermal Drug Delivery Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Transdermal Corp
-
11.5.1 Transdermal Corp Company Details
-
11.5.2 Transdermal Corp Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Transdermal Corp Passive Transdermal Drug Delivery Main Business and Markets Served
-
11.5.4 Transdermal Corp Passive Transdermal Drug Delivery Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Corium International Inc
-
11.6.1 Corium International Inc Company Details
-
11.6.2 Corium International Inc Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Corium International Inc Passive Transdermal Drug Delivery Main Business and Markets Served
-
11.6.4 Corium International Inc Passive Transdermal Drug Delivery Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Actavis Inc
-
11.7.1 Actavis Inc Company Details
-
11.7.2 Actavis Inc Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Actavis Inc Passive Transdermal Drug Delivery Main Business and Markets Served
-
11.7.4 Actavis Inc Passive Transdermal Drug Delivery Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 GlaxoSmithKline plc
-
11.8.1 GlaxoSmithKline plc Company Details
-
11.8.2 GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 GlaxoSmithKline plc Passive Transdermal Drug Delivery Main Business and Markets Served
-
11.8.4 GlaxoSmithKline plc Passive Transdermal Drug Delivery Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Bayer AG
-
11.9.1 Bayer AG Company Details
-
11.9.2 Bayer AG Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Bayer AG Passive Transdermal Drug Delivery Main Business and Markets Served
-
11.9.4 Bayer AG Passive Transdermal Drug Delivery Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Echo Therapeutics Inc
-
11.10.1 Echo Therapeutics Inc Company Details
-
11.10.2 Echo Therapeutics Inc Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Echo Therapeutics Inc Passive Transdermal Drug Delivery Main Business and Markets Served
-
11.10.4 Echo Therapeutics Inc Passive Transdermal Drug Delivery Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 3M
-
11.11.1 3M Company Details
-
11.11.2 3M Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 3M Passive Transdermal Drug Delivery Main Business and Markets Served
-
11.11.4 3M Passive Transdermal Drug Delivery Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Boehringer Ingelheim GmbH
-
11.12.1 Boehringer Ingelheim GmbH Company Details
-
11.12.2 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Main Business and Markets Served
-
11.12.4 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product Portfolio
-
11.12.5 Recent Research and Development Strategies
12 Global Passive Transdermal Drug Delivery Market Outlook by Types and Applications to 2028
-
12.1 Global Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Microfluidics Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Smart Pill Technology (SPT) Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Passive Transdermal Drug Delivery Market Analysis and Outlook to 2028
-
13.1 Global Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.2.2 Canada Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.2.3 Mexico Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.3.2 UK Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.3.3 Spain Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.3.4 Belgium Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.3.5 France Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.3.6 Italy Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.3.7 Denmark Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.3.8 Finland Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.3.9 Norway Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.3.10 Sweden Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.3.11 Poland Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.3.12 Russia Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.3.13 Turkey Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.4.2 Japan Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.4.3 India Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.4.4 South Korea Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.4.8 Thailand Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.4.9 Singapore Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.4.11 Philippines Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.5.2 Colombia Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.5.3 Chile Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.5.4 Argentina Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.5.6 Peru Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.6.3 Oman Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.6.4 Qatar Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.7.2 South Africa Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.7.3 Egypt Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.7.4 Algeria Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Passive Transdermal Drug Delivery Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Passive Transdermal Drug Delivery
-
Figure of Passive Transdermal Drug Delivery Picture
-
Table Global Passive Transdermal Drug Delivery Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Passive Transdermal Drug Delivery Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Microfluidics Consumption and Growth Rate (2017-2022)
-
Figure Global Smart Pill Technology (SPT) Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Passive Transdermal Drug Delivery Consumption by Country (2017-2022)
-
Table North America Passive Transdermal Drug Delivery Consumption by Country (2017-2022)
-
Figure United States Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Canada Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Mexico Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Table Europe Passive Transdermal Drug Delivery Consumption by Country (2017-2022)
-
Figure Germany Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure UK Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Spain Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Belgium Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure France Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Italy Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Denmark Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Finland Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Norway Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Sweden Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Poland Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Russia Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Turkey Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Table APAC Passive Transdermal Drug Delivery Consumption by Country (2017-2022)
-
Figure China Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Japan Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure India Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure South Korea Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Thailand Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Singapore Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Philippines Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Table South America Passive Transdermal Drug Delivery Consumption by Country (2017-2022)
-
Figure Brazil Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Colombia Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Chile Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Argentina Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Peru Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Table GCC Passive Transdermal Drug Delivery Consumption by Country (2017-2022)
-
Figure Bahrain Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Oman Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Qatar Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Table Africa Passive Transdermal Drug Delivery Consumption by Country (2017-2022)
-
Figure Nigeria Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure South Africa Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Egypt Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure Algeria Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Table Oceania Passive Transdermal Drug Delivery Consumption by Country (2017-2022)
-
Figure Australia Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Passive Transdermal Drug Delivery Consumption and Growth Rate (2017-2022)
-
Table Novartis AG Company Details
-
Table Novartis AG Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Passive Transdermal Drug Delivery Main Business and Markets Served
-
Table Novartis AG Passive Transdermal Drug Delivery Product Portfolio
-
Table Mylan NV Company Details
-
Table Mylan NV Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan NV Passive Transdermal Drug Delivery Main Business and Markets Served
-
Table Mylan NV Passive Transdermal Drug Delivery Product Portfolio
-
Table Noven Pharmaceuticals Inc Company Details
-
Table Noven Pharmaceuticals Inc Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Noven Pharmaceuticals Inc Passive Transdermal Drug Delivery Main Business and Markets Served
-
Table Noven Pharmaceuticals Inc Passive Transdermal Drug Delivery Product Portfolio
-
Table Johnson & Johnson (Janssen Pharmaceuticals Inc) Company Details
-
Table Johnson & Johnson (Janssen Pharmaceuticals Inc) Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson (Janssen Pharmaceuticals Inc) Passive Transdermal Drug Delivery Main Business and Markets Served
-
Table Johnson & Johnson (Janssen Pharmaceuticals Inc) Passive Transdermal Drug Delivery Product Portfolio
-
Table Transdermal Corp Company Details
-
Table Transdermal Corp Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Transdermal Corp Passive Transdermal Drug Delivery Main Business and Markets Served
-
Table Transdermal Corp Passive Transdermal Drug Delivery Product Portfolio
-
Table Corium International Inc Company Details
-
Table Corium International Inc Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Corium International Inc Passive Transdermal Drug Delivery Main Business and Markets Served
-
Table Corium International Inc Passive Transdermal Drug Delivery Product Portfolio
-
Table Actavis Inc Company Details
-
Table Actavis Inc Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Actavis Inc Passive Transdermal Drug Delivery Main Business and Markets Served
-
Table Actavis Inc Passive Transdermal Drug Delivery Product Portfolio
-
Table GlaxoSmithKline plc Company Details
-
Table GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Passive Transdermal Drug Delivery Main Business and Markets Served
-
Table GlaxoSmithKline plc Passive Transdermal Drug Delivery Product Portfolio
-
Table Bayer AG Company Details
-
Table Bayer AG Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Passive Transdermal Drug Delivery Main Business and Markets Served
-
Table Bayer AG Passive Transdermal Drug Delivery Product Portfolio
-
Table Echo Therapeutics Inc Company Details
-
Table Echo Therapeutics Inc Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Echo Therapeutics Inc Passive Transdermal Drug Delivery Main Business and Markets Served
-
Table Echo Therapeutics Inc Passive Transdermal Drug Delivery Product Portfolio
-
Table 3M Company Details
-
Table 3M Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table 3M Passive Transdermal Drug Delivery Main Business and Markets Served
-
Table 3M Passive Transdermal Drug Delivery Product Portfolio
-
Table Boehringer Ingelheim GmbH Company Details
-
Table Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Main Business and Markets Served
-
Table Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product Portfolio
-
Figure Global Microfluidics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Smart Pill Technology (SPT) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Passive Transdermal Drug Delivery Consumption Forecast by Country (2022-2028)
-
Table North America Passive Transdermal Drug Delivery Consumption Forecast by Country (2022-2028)
-
Figure United States Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Passive Transdermal Drug Delivery Consumption Forecast by Country (2022-2028)
-
Figure Germany Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Passive Transdermal Drug Delivery Consumption Forecast by Country (2022-2028)
-
Figure China Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Passive Transdermal Drug Delivery Consumption Forecast by Country (2022-2028)
-
Figure Brazil Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Passive Transdermal Drug Delivery Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Passive Transdermal Drug Delivery Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Passive Transdermal Drug Delivery Consumption Forecast by Country (2022-2028)
-
Figure Australia Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Passive Transdermal Drug Delivery Consumption Forecast and Growth Rate (2022-2028)
-
